tm logo
RIJON LABS
ABANDONED SECTION 36

on 23 Nov 2022

Last Applicant/ Owned by

GARY FLAX

4923 Cape Coral DriveDallas, TX 75287

US

Serial Number

1960744 filed on 03rd May 2019

RIJON LABS

Trademark usage description

anti-diabetic pharmaceuticals; antidiabetic pharmaceuticals; anti-epileptic pharmaceutical preparations; cardiovascular pharmaceutical preparations; d Read More

Classification Information


Class [005]
Anti-diabetic pharmaceuticals; antidiabetic pharmaceuticals; anti-epileptic pharmaceutical preparations; cardiovascular pharmaceutical preparations; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; inhaled pharmaceutical preparations for treating respiratory diseases and disorders; intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; intravenous fluids used for the delivery of pharmaceutical preparations; pharmaceutical anti-allergic preparations and substances; pharmaceutical antiallergic preparations and substances; pharmaceutical antitussive-cold preparations; pharmaceutical astringents; pharmaceutical cold preparations; pharmaceutical cough preparations; pharmaceutical for the treatment of erectile dysfunction; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases; pharmaceutical preparations for inducing erections; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for preventing skin blemishes during pregnancy; pharmaceutical preparations for reducing cholesterol; pharmaceutical preparations for suppressing tumours; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the prevention of stretch marks; pharmaceutical preparations for the relief of insect bites; pharmaceutical preparations for the relief of pain; pharmaceutical preparations for the treatment of acne; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for the treatment of asthma; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical preparations for the treatment of blood disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for the treatment of bone fractures; pharmaceutical preparations for the treatment of brain diseases and disorders, namely, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, multiple sclerosis; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of carpal tunnel syndrome; pharmaceutical preparations for the treatment of chronic pain; pharmaceutical preparations for the treatment of cranial or facial nerve disorders; pharmaceutical preparations for the treatment of dandruff; pharmaceutical preparations for the treatment of degenerative nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis; pharmaceutical preparations for the treatment of dental and oral diseases; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders; pharmaceutical preparations for the treatment of diseases, disorders and infections of the spinal cord systems and related cartilage and tissue; pharmaceutical preparations for the treatment of drug and alcohol abuse; pharmaceutical preparations for the treatment of epilepsy; pharmaceutical preparations for the treatment of erectile dysfunction; pharmaceutical preparations for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical preparations for the treatment of genito-urinary and pelvic diseases, disorders and infections, namely infertility, sexually transmitted diseases, incontinence and sexual dysfunction; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of glaucoma; pharmaceutical preparations for the treatment of gout; pharmaceutical preparations for the treatment of headaches; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for the treatment of hypercholesterolemia; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the treatment of infectious diseases, namely respiratory infections, eye infections; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; pharmaceutical preparations for the treatment of inflammatory muscle diseases and disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia; pharmaceutical preparations for the treatment of metabolic disorders, namely diabetes, bulimia nervosa, anorexia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of migraine; pharmaceutical preparations for the treatment of motion sickness; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of myalgia and neuralgia; pharmaceutical preparations for the treatment of neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy; pharmaceutical preparations for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders; pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, myasthenia gravis, Huntington's disease; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the treatment of Parkinson's disease; pharmaceutical preparations for the treatment of physical and psychological addictions, namely, gambling addiction, eating disorders and addictions, nicotine addiction, Internet addiction, drug addiction; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders; pharmaceutical preparations for the treatment of respiratory diseases, disorders and infections; pharmaceutical preparations for the treatment of skin irritations, namely bee stings, sunburn, rashes, sores, corns, calluses, and acne; pharmaceutical preparations for the treatment of smoking cessation; pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; pharmaceutical preparations for the treatment of the diseases, disorders and infections of the central nervous system namely brain, movement, ocular motility and spinal cord diseases; pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of varicose veins; pharmaceutical preparations for the treatment of vascular diseases; pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations for treating allergic rhinitis; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating asthma; pharmaceutical preparations for treating chloasma; pharmaceutical preparations for treating dandruff; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating gastrointestinal disorders; pharmaceutical preparations for treating halitosis; pharmaceutical preparations for treating heatstroke; pharmaceutical preparations for treating hypoglycaemia; pharmaceutical preparations for treating hypoglycemia; pharmaceutical preparations for treating malignant tumours; pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for treating sunburn; pharmaceutical preparations for treating the symptoms of radiation sickness; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in discouraging the smoking habit; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for use in ocular disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for wounds; pharmaceutical products for ophthalmological use; pharmaceutical products for the treatment of cancer; pharmaceutical products for treating respiratory diseases; pharmaceutical solutions used in dialysis; pharmaceuticals for the treatment of bone diseases; pharmaceuticals for treating the symptoms of radiation sickness; radioactive pharmaceutical preparations for in vivo diagnostic or therapeutic use; radioactive pharmaceutical preparations for in vivo diagnostics or therapeutic use; siccatives for use in the manufacture of pharmaceuticals; sunburn preparations for pharmaceutical purposes; synthetic peptides for pharmaceutical purposes; unit dose capsules sold empty for pharmaceutical use; veterinary pharmaceutical preparations for animals and poultry to give newborn animals and birds a healthy start; veterinary pharmaceutical preparations for periodontal diseases; veterinary pharmaceutical preparations for respiratory and reproductive diseases in cattle; veterinary pharmaceutical preparations for the treatment of arthritis, muscle soreness and sprains;; veterinary pharmaceutical preparations for the treatment of bacterial infections in dogs; veterinary pharmaceutical preparations for the treatment of infectious diseases in poultry; veterinary pharmaceutical preparations for the treatment of infectious diseases, namely, respiratory infections, eye infections, topical infections; veterinary pharmaceutical preparations for the treatment of infectious diseases, namely, swine dysentery, bacterial enteritis, Bluecomb, pneumonia; veterinary pharmaceutical preparations for the treatment of nutritional muscular dystrophy;; veterinary pharmaceutical preparations for the treatment of parasites; veterinary pharmaceutical preparations for the treatment of swine bacterial infectious diseases; veterinary pharmaceutical preparations for the treatment of vitamin deficiencies;; veterinary pharmaceutical preparations for udder care;


Classification kind code

11

Mark Details


Serial Number

1960744

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 14
on 31st Aug 2022
Default Notice Sent
Submitted for opposition 190
on 09th Feb 2022
Registration Pending
Submitted for opposition 191
on 09th Feb 2022
Registration Fee Notice Sent
Submitted for opposition 42
on 17th Nov 2021
Advertised
Submitted for opposition 26
on 25th Oct 2021
Approved
Submitted for opposition 27
on 25th Oct 2021
Approval Notice Sent
Submitted for opposition 22
on 19th Oct 2021
Search Recorded
Submitted for opposition 31
on 07th May 2019
Formalized
Submitted for opposition 30
on 03rd May 2019
Filed
Submitted for opposition 1
on 03rd May 2019
Created